Pink Unicorn: Affected lots may contain the undeclared ingredient sildenafil (updated risk classification and reason for recall)
Last updated
Summary
Product
Pink Unicorn
Issue
Health products - Product quality
Health products - Unauthorized product
What to do
Consult your health care professional if you have any health concerns.
Distribution
Quebec
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Pink Unicorn |
Pink Unicorn |
Not licensed |
Capsule |
N/A |
All lots |
Issue
Affected lots may contain the undeclared ingredient sildenafil.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
7067941 Canada Inc. (D.N.B.)
1264 rue Brodeur, Saint-Paul-d'Abbotsford
Québec, J0E1A0
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Quebec
Recall class
Type I
Identification number
RA-74105
History
Change log
2023-08-22: Updated risk classification and reason for recall
Get notified
Receive notifications for new and updated recalls and alerts by category.